Patrick Haig

Patrick Haig is a co-founder at Assembler Labs, a startup studio based in downtown Detroit. Before moving to Detroit in 2018, he was Director of Product at TUNE, a Seattle-based, venture-backed mobile marketing analytics company.

Recent posts

We Did It In Detroit, And So Can You: Fundraising Lessons Learned
As the co-founder of Assembler Labs, a Detroit-based startup studio, I breathed a big sigh of relief after we closed our inaugural round of fundraising at the end of March.... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More

F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections

Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

G1 Vets Launch Arc Therapeutics to Take on New Cancer Target

Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup

Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Elevation Oncology Debuts With $32.5M to Develop Targeted Cancer Drugs

Two Days, Six IPOs, and $1B Raised for Biotech Research & More

Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire

The Xcelerate Keynote Series – Part of Biotech Week Boston

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

Patrick Haig

Recent posts

We Did It In Detroit, And So Can You: Fundraising Lessons Learned

Underwriters and Partners

The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development

Potency Assay Development for Cell and Gene Therapy Products

The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

Xconomy on Demand

We offer a number of ways to subscribe for free!